| Clinical data | |
|---|---|
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.230.426 |
| Chemical and physical data | |
| Formula | C16H23NO |
| Molar mass | 245.366 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| | |
Pyrovalerone (Centroton,4-Methyl-β-keto-prolintane,Thymergix,O-2371)[2] is acentral nervous system (CNS)stimulant thatacts as anorepinephrine–dopamine reuptake inhibitor (NDRI). It wasdeveloped in the 1980s and had briefly been approved in Spain and France forchronic fatigue orlethargy[3] and as anappetite suppressant, but was withdrawn from both markets around 2001 due to safety concerns including problems withabuse anddependence.[4] It is closely related on astructural level to a number of other cathinone stimulants, such asα-PVP,MDPV andprolintane.
Side effects of pyrovalerone includedecreased appetite,anxiety, fragmentedsleep orinsomnia, andtrembling,shaking, ormuscle tremors.Withdrawal symptoms following abuse upon discontinuation often results indepression.
TheR-enantiomer of pyrovalerone is devoid of pharmacologic activity.[5]
| DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors) |
| ||||||||||||||
| SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors) |
| ||||||||||||||
| VMATsTooltip Vesicular monoamine transporters | |||||||||||||||
| Others |
| ||||||||||||||
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones | |||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| Stimulants |
|
|---|---|
| Depressants |
|
| Hallucinogens |
|
| Entactogens |
|
| Psychiatric drugs |
|
| Others |
|
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byadding missing information. |